Insider: Cohen Yuval Chief Executive Officer - Corbus Pharmaceuticals Holdings, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 174,316 | 0 | 174,316 |
| Value | $1,772,793.72 | $0.00 | $1,772,793.72 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/13/2026 | DDS | 13,871 | Direct | COM | $7.78 | $107,952.44 | 174,316 |
| 10/27/2025 | DDS | 8,973 | Direct | COM | $17.14 | $153,797.22 | 138,187 |
| 10/24/2025 | DDS | 18,660 | Direct | COM | $17.01 | $317,406.60 | 138,187 |
| 02/14/2025 | DDS | 7,134 | Direct | COM | $8.76 | $62,464.59 | 138,187 |
| 06/18/2024 | DDS | 11,667 | Direct | COM | $42.24 | $492,779.08 | 84,400 |
| 06/18/2024 | DDS | 1,770 | Direct | COM | $42.24 | $74,759.49 | 84,400 |
| 06/18/2024 | DDS | 7,179 | Direct | COM | $42.24 | $303,219.42 | 77,221 |
| 06/18/2024 | DDS | 2,322 | Direct | COM | $42.24 | $98,074.31 | 84,400 |
| 06/17/2024 | DDS | 9,333 | Direct | COM | $46.02 | $429,507.46 | 84,400 |
| 06/17/2024 | DDS | 1,770 | Direct | COM | $46.02 | $81,455.93 | 84,400 |
| 06/14/2024 | DDS | 12,487 | Direct | COM | $50.17 | $626,425.34 | 84,400 |
| 06/14/2024 | DDS | 16,830 | Direct | COM | $50.17 | $844,297.15 | 84,400 |
| 08/10/2022 | AAP | 3,800 | Direct | COM | $0.26 | $1,003.20 | 98,230 |
| 05/16/2022 | AAP | 10,500 | Direct | COM | $0.25 | $2,625.00 | 94,430 |
| 03/09/2022 | AAP | 8,600 | Direct | COM | $0.37 | $3,182.00 | 83,930 |
| 11/11/2020 | AAP | 4,240 | Direct | COM | $1.21 | $5,126.16 | 75,330 |
| 03/17/2020 | AAP | 4,300 | Direct | COM | $3.49 | $15,007.00 | 71,090 |
| 11/12/2019 | AAP | 1,430 | Direct | COM | $4.26 | $6,091.80 | 66,790 |
| 08/12/2019 | AAP | 1,175 | Direct | COM | $6.06 | $7,115.80 | 65,360 |
| 05/13/2019 | AAP | 995 | Direct | COM | $6.99 | $6,954.85 | 64,185 |
| 03/14/2019 | AAP | 1,530 | Direct | COM | $6.49 | $9,929.70 | 63,190 |
| 05/15/2018 | AAP | 1,725 | Direct | COM | $5.85 | $10,091.25 | 61,660 |
| 03/14/2018 | AAP | 1,160 | Direct | COM | $6.89 | $7,986.60 | 59,935 |
| 11/10/2017 | AAP | 1,000 | Direct | COM | $7.17 | $7,168.50 | 58,775 |
| 08/11/2017 | AAP | 1,695 | Direct | COM | $6.00 | $10,170.00 | 57,775 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research